| 英文別名 |
H-Gly-His-Lys-OH;Gly-His-Lys acetate salt;Gly-His-Lys-OH·AcOH;Liver Cell Growth Factor;GHK;Oligopeptide-1;Tripeptide-1/Kollaren/GHK;Tripeptide-1;Liver-Cell Growth Factor acetate salt;NS00060679;acetic acid;(2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid;Gly-His-Lys acetate salt, BioXtra, gamma-irradiated, suitable for cell culture;8AA809EUS9;EINECS 277-125-4;Gly-His-Lys acetate;SCHEMBL810924;Gly-His-Lys acetate salt, >=97% (TLC);UNII-8AA809EUS9;Liver Cell Growth Factor acetate salt, BT-242 (H-Gly-L-His-L-Lys-OH.CH3CO2H);(S)-6-Amino-2-((S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido)hexanoic acid acetic acid salt;Tripeptide-1 Acetate pound 72957-37-0 pound notfree pound(c);(S)-6-Amino-2-((S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido)hexanoicacidcompoundwithaceticacid(1:1);AMY30913;(2S)-6-AMINO-2-[(2S)-2-(2-AMINOACETAMIDO)-3-(1H-IMIDAZOL-4-YL)PROPANAMIDO]HEXANOIC ACID; ACETIC ACID;MFCD00012699;glycyl-histidyl-lysine monoacetate;AKOS015913925;Q27270101;GHK ACETATE [MI];(S)-6-Amino-2-((S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido)hexanoic acid compound with acetic acid (1:1);72957-37-0;Tripeptide-1 Acetate??72957-37-0,free??;L-LYSINE, N2-(N-GLYCYL-L-HISTIDYL)-, MONOACETATE;AS-75043;N2-(N-Glycyl-L-histidyl)-L-lysine monoacetate;L-Lysine, glycyl-L-histidyl-, monoacetate;glycyl-L-histidyl-L-lysine compound with acetic acid (1:1);GHK ACETATE;Prezatide monoacetate;CS-W011705;PC-1020 MONOACETATE;Tripeptide-1?;Tripeptide-1?;MGNUTAFMLGJBGV-ACMTZBLWSA-N;MGNUTAFMLGJBGV-ACMTZBLWSA-N;D92811;D92811;TP2314;TP2314;COPPER PEPTIDE ACETATE;COPPER PEPTIDE ACETATE |
γ-L-谷氨酰-α-萘酰胺/γ-L-谷氨酰-1-萘酰胺/N-(γ-L-谷氨酰)-1-萘胺/L-谷氨酰-1-萘胺/γ-L-谷氨酰-α-萘胺/γ-L-Glutamyl-α-naphthylamide
N-芴甲氧羰基-N'-甲苯磺酰基-L-精氨酸/Nα-FMOC-Nω-TOSYL-L-精氨酸/FMOC-對甲苯磺酰-精氨酸/N-芴甲氧羰基-甲苯磺?；?精氨酸/FMOC-Nω-(4-甲基磺酰)-L-精氨
多巴胺鹽酸鹽/3-羥基酪胺鹽酸鹽/鹽酸-3-羥基酪胺/兒茶酚乙胺鹽酸鹽/3,4-二羥基-β-苯基乙胺鹽酸鹽/4-(2-氨基乙基)-1,2-苯二酚鹽酸鹽/Dopamine hydrochloride
